Volume 5 - # 2
electronic bulletin The Program of Retinopathy of Prematurity Launched Successfully in Armenia
All premature infants born in Armenia onwards undergo regular eye screenings and treatment against the eye disease of Retinopathy of Prematurity (ROP). This was made possible through the efforts of the Armenian EyeCare Project (AECP) and its partners. There are now well-trained experts and necessary equipment available in Armenia. The Armenian EyeCare Project (AECP) has been fighting against different eye diseases in our country for almost two decades. For this very purpose, several important ophthalmologic departments were established at the AECP partnering eye clinics during that time. The AECP medical missions traditionally visit Armenia every year to support the sustainability development and capacity building of those departments. Each medical mission is concentrated around a specific eye disorder, enabling the fully fledged diagnostics, prevention, and treatment of that particular disease. Through joint activities, the AECP and its partners have greatly contributed to Armenia’s image of an advanced ophthalmologic center in the region. Modern ophthalmologic services allow fighting against almost all types of eye diseases and disorders in our country, in compliance with highest international standards. Nonetheless, there are still several eye diseases in Armenia that require serious actions to be taken and relevant information to be shared with the Armenian doctors and general population. Retinopathy of Prematurity (ROP) is one of those diseases. It affects the blood vessels in
sight
the back of the eye and threatens the infant to go blind because of retinal detachment. The risk group for ROP is defined among infants born with a birth weight of less than 1500 g or with a gestational age of 30 weeks or less. Well before starting a program the AECP management had researched the tendencies of the ROP in our country. The problem of ROP was emerging, as evidenced by the practicing Armenian neonatologists and ophthalmologists who encountered more and more of such cases. Annually, around 500-600 infants belonging to that risk group were born, and this number was on an increasing curve. The ROP screening, early detection, and treatment were not available in Armenia. As a result, the vision problems of these children were revealed too late, making treatment less effective or useful at all. Aside from that, children with ROP had no option but to go abroad to receive treatment. All mentioned factors assured the AECP and its partners that a special ROP program should be launched and a respective medical mission to Armenia should be organized. The results of the 36th AECP medical mission continued on page 2 >>>
IN THIS ISSUE The Program of Retinopathy of Prematurity Launched Successfully in Armenia.
Prestigious Award ReCEIVED
Swiss Foundation Sponsoring GEBAUER STIFTUNG
Gift of the sight
bringing
to armenian eyes the armenian eyecare project aygestan 5, house 7 yerevan, armenia phone (374 10) 55 90 68 fax (374 10) 57 76 94 aecp@cornet.am
p.o. box 5630 newport beach, ca 92662 phone 949.675.5767 fax 949 673.2356 aecp@eyecareproject.com
Founded in 1992, in the United States by an American-Armenian ophthalmologist Roger Ohanesian, M.D., the Armenian EyeCare Project (AECP) is a California based nonprofit corporation dedicated to the elimination of preventable blindness in Armenia. In 2003, the AECP established an office in Yerevan and launched its program “Bringing Sight to Armenian Eyes.” The Initiative has five comprehensive, integrated components developed to eliminate preventable blindness. They include direct patient care, medical education and training, public education, research and capacity building. More than 265,000 people have been screened and over 11,000 sight-saving surgeries and laser trea ments have been performed in the Mobile Eye Hospital. The AECP has been a USAID partner since 2004.
www.eyecareproject.com
This publication was made possible with the support of the American People through the U.S. Agency for International Development (USAID) and the Armenian EyeCare Project (AECP). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the U.S. Government.